Del Borgo Laboratory
Macro Therapeutics Lab
Welcome to the Del Borgo Lab
The Macro Therapeutics lab centres around the design and delivery of macromolecules, in particular, synthetic peptides as drugs. Currently we are focusing on a delivery strategy to afford functional materials that can be tailored for applications in drug delivery and nanomedicine.
We're part of the Monash Biomedicine Discovery Institute, and a member of the Cardiovascular Disease and Neuroscience Programs, and the Department of Pharmacology.
Dr Mark Del Borgo
My global research connections, partners and funding can be viewed on my Monash Research Profile.
If you are a student interested in doing research in our lab, visit Supervisor Connect.
Click the links below to connect with me on Twitter, ORCID, Google Scholar and LinkedIn.
Our research
The ability of peptides to self-assemble through non-covalent interactions spontaneously or in response to specific triggers has been the focus of researchers to build materials that can be applied to a range of applications. This allows for the tailoring of materials through the chemical modification of the peptide building blocks. We now have a wide number of ligands that can be attached to the peptide building blocks that will enable fine tuning of physiological function and material characteristics that is crucial for cell signalling, tissue integration and drug delivery.
-
Drug delivery using injectable β-peptide hydrogels to treat cardiovascular and neurological conditions
-
Encapsulation of stem cells and exosomes within β-peptide hydrogels as novel therapies
-
Lab members
We are committed to excellence in research.
Join Our Lab
We're always interested in collaborating with bright and motivated researchers, clinicians and industry. Whether you want to research, study or partner with us to accelerate our discoveries, find out about the work we do.